Product Code: ETC417020 | Publication Date: Aug 2023 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
The India Buprenorphine Market is projected to witness mixed growth rate patterns during 2025 to 2029. Growth accelerates to 3.51% in 2028, following an initial rate of 2.52%, before easing to 2.77% at the end of the period.
The buprenorphine market in India is evolving as the country grapples with opioid addiction issues. Buprenorphine, a medication used in opioid replacement therapy, has gained significance in the India healthcare system. It plays a vital role in treating opioid addiction, reducing harm, and improving the quality of life for affected individuals. The market faces the challenge of balancing accessibility for patients in need while preventing misuse and diversion.
The India buprenorphine market is primarily driven by its use in the healthcare sector for pain management and opioid addiction treatment. Buprenorphine is a critical medication for individuals undergoing opioid replacement therapy. The market`s growth is influenced by the increasing awareness of opioid addiction issues, the expansion of healthcare infrastructure, and government initiatives to address substance abuse and addiction. Regulatory controls and healthcare policies also play a significant role in the market`s development.
The India Buprenorphine market faces regulatory challenges and concerns about substance abuse. Buprenorphine is a controlled substance, and strict regulations are in place to prevent its misuse and diversion. Ensuring that buprenorphine is used appropriately in opioid addiction treatment programs is essential. The market must also address the stigma associated with opioid addiction and promote awareness about the benefits of buprenorphine therapy.
The India buprenorphine market faced challenges during the COVID-19 pandemic. The market saw disruptions in the production and distribution of buprenorphine, a key medication used in opioid addiction treatment. However, as the healthcare system adapted to the pandemic`s demands, the market gradually stabilized, with continued demand for addiction treatment.
The India Buprenorphine market is supported by key pharmaceutical companies that manufacture and supply buprenorphine-based medications. Notable players in this segment include Sun Pharmaceutical Industries Ltd, Macleods Pharmaceuticals Ltd, Intas Pharmaceuticals Ltd, and Cipla Limited. These companies are essential contributors to the healthcare sector in India, offering medications that are integral to the management of opioid dependence and pain control, contributing to public health and well-being.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Buprenorphine Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Buprenorphine Market Revenues & Volume, 2021 & 2031F |
3.3 India Buprenorphine Market - Industry Life Cycle |
3.4 India Buprenorphine Market - Porter's Five Forces |
3.5 India Buprenorphine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 India Buprenorphine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 India Buprenorphine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Buprenorphine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 India Buprenorphine Market Trends |
6 India Buprenorphine Market, By Types |
6.1 India Buprenorphine Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 India Buprenorphine Market Revenues & Volume, By Application, 2021-2031F |
6.1.3 India Buprenorphine Market Revenues & Volume, By Analgesic, 2021-2031F |
6.1.4 India Buprenorphine Market Revenues & Volume, By Opioid Antagonist, 2021-2031F |
6.2 India Buprenorphine Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 India Buprenorphine Market Revenues & Volume, By Injectables, 2021-2031F |
6.2.3 India Buprenorphine Market Revenues & Volume, By Sublingual, 2021-2031F |
6.2.4 India Buprenorphine Market Revenues & Volume, By Transdermal Patches, 2021-2031F |
6.3 India Buprenorphine Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 India Buprenorphine Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.3.3 India Buprenorphine Market Revenues & Volume, By Retail Pharmacies, 2021-2031F |
6.3.4 India Buprenorphine Market Revenues & Volume, By Online Pharmacies, 2021-2031F |
7 India Buprenorphine Market Import-Export Trade Statistics |
7.1 India Buprenorphine Market Export to Major Countries |
7.2 India Buprenorphine Market Imports from Major Countries |
8 India Buprenorphine Market Key Performance Indicators |
9 India Buprenorphine Market - Opportunity Assessment |
9.1 India Buprenorphine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 India Buprenorphine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 India Buprenorphine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Buprenorphine Market - Competitive Landscape |
10.1 India Buprenorphine Market Revenue Share, By Companies, 2024 |
10.2 India Buprenorphine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |